This educational activity may contain discussion of agents that are not approved for use by the FDA and/or investigational (“off-label”) uses of agents that are approved by the FDA. The planners of this activity do not recommend the use of any agent outside of its labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each agent for information on its approved indications, contraindications, warnings, and other, related information.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
As of August 1, 2013, pharmaceutical companies are required by the new Centers for Medicare & Medicaid Services (CMS) Open Payments program (aka, the Physician Payments Sunshine Act) to account for certain transfers of value provided to physicians, including certain meals served to attendees of CME activities, unless specific factors are met.
AXIS and its partners have systems in place to fully comply with the Open Payments system.
In compliance with the Americans with Disabilities Act, AXIS Medical Education will make every reasonable effort to accommodate your request. For any special requests, please contact AXIS at email@example.com before the activity dates.
AXIS Medical Education affirms that the content and format of the certified activity and its related materials promote improvements and quality in healthcare and do not promote a specific proprietary business interest of a commercial entity. To this end, AXIS employs several strategies to ensure the absence of commercial bias, including, but not limited to, review of all planned content for certified activities to ensure adherence to the Accreditation Council for Continuing Medical Education’s content validation guidelines, and resolution of any actual or perceived conflicts of interest that exist.
We employ several metrics during review of content materials, including: